Search Results - "Federico, Giorgia"
-
1
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice
Published in Haematologica (Roma) (01-03-2021)“…Nuclear receptor coactivator 4 (NCOA4) promotes ferritin degradation and Ncoa4-ko mice in a C57BL/6 background show microcytosis and mild anemia, aggravated by…”
Get full text
Journal Article -
2
NCOA4 Deficiency Impairs Systemic Iron Homeostasis
Published in Cell reports (Cambridge) (26-01-2016)“…The cargo receptor NCOA4 mediates autophagic ferritin degradation. Here we show that NCOA4 deficiency in a knockout mouse model causes iron accumulation in the…”
Get full text
Journal Article -
3
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
Published in Scientific reports (09-08-2021)“…We have recently described Pz-1, a benzimidazole-based type-2 RET and VEGFR2 inhibitor. Based on a kinome scan, here we show that Pz-1 is also a potent (IC 50 …”
Get full text
Journal Article -
4
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology
Published in Journal of medicinal chemistry (14-05-2020)“…RET receptor tyrosine kinase is a driver oncogene in human cancer. We recently identified the clinical drug candidate Pz-1, which targets RET and VEGFR2. A key…”
Get full text
Journal Article -
5
Tamoxifen erythroid toxicity revealed by studying the role of nuclear receptor co-activator 4 in erythropoiesis
Published in Haematologica (Roma) (01-08-2019)Get full text
Journal Article -
6
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology
Published in Angewandte Chemie International Edition (20-07-2015)“…Oncogenic conversion of the RET (rearranged during transfection) tyrosine kinase is associated with several cancers. A fragment‐based chemical screen led to…”
Get full text
Journal Article -
7
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition
Published in Frontiers in immunology (2019)“…The ability of pathogens to sequester iron from their host cells and proteins affects their virulence. Moreover, iron is required for various innate host…”
Get full text
Journal Article -
8
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
Published in PloS one (05-06-2015)“…Oncogenic mutation of the RET receptor tyrosine kinase is observed in several human malignancies. Here, we describe three novel type II RET tyrosine kinase…”
Get full text
Journal Article -
9
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
Published in Genes (15-04-2020)“…Following the identification of the BCR-ABL1 (Breakpoint Cluster Region-ABelson murine Leukemia) fusion in chronic myelogenous leukemia, gene fusions…”
Get full text
Journal Article -
10
NCOA4 links iron bioavailability to DNA metabolism
Published in Cell reports (Cambridge) (16-08-2022)“…Iron is essential for deoxyribonucleotides production and for enzymes containing an Fe-S cluster involved in DNA replication and repair. How iron…”
Get full text
Journal Article -
11
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model
Published in The Journal of clinical investigation (17-05-2021)“…Anemia in β-thalassemia is related to ineffective erythropoiesis and reduced red cell survival. Excess free heme and accumulation of unpaired α-globin chains…”
Get full text
Journal Article -
12
NCOA4 Links Iron Bioavailability to DNA Metabolism
Published in Blood (08-12-2017)“…Iron (Fe) is a key element of many proteins involved in primary cellular processes such as energy production, DNA synthesis and repair (Fuss et al. 2015)…”
Get full text
Journal Article -
13
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis
Published in Antioxidants & redox signaling (01-01-2018)“…Iron overload (IO) is a life-threatening complication of chronic hemolytic disorders such as β-thalassemia. IO results in severe cellular oxidative damage,…”
Get more information
Journal Article -
14
The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia
Published in Blood (08-12-2017)“…The Nuclear Receptor Coactivator 4 (NCOA4) protein has been recently recognized as a novel player in iron metabolism contributing to regulation of cell and…”
Get full text
Journal Article -
15
Iron and Ferritin Modulate MHC Class I Expression and NK Cells Recognition
Published in Frontiers in immunology (26-02-2019)Get full text
Journal Article -
16
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a [beta]-thalassemia mouse model
Published in The Journal of clinical investigation (15-05-2021)“…Anemia in [beta]-thalassemia is related to ineffective erythropoiesis and reduced red cell survival. Excess free heme and accumulation of unpaired…”
Get full text
Journal Article -
17
Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia
Published in Molecular and cellular endocrinology (15-01-2018)“…Here we describe a conditional doxycycline-dependent mouse model of RET/PTC3 (NCOA4-RET) oncogene-induced thyroid tumorigenesis. In these mice, after 10 days…”
Get full text
Journal Article -
18
The chemokine scavenging receptor D6/ACKR2 is a target of miR-146a in thyroid cancer
Published in Genes & cancer (01-05-2017)“…We have previously shown that miR-146a, a NF-κB-regulated microRNA, is strongly expressed in human specimens and cell lines derived from anaplastic thyroid…”
Get full text
Journal Article -
19
Fragment-based discovery of a dual pan-RET/VEGFR2 kinase inhibitor optimized for single-agent polypharmacology1
Published in Angewandte Chemie International Edition (30-06-2015)“…Oncogenic conversion of the RET (rearranged during transfection) tyrosine kinase is associated with several cancers. A fragment-based chemical screen lead to…”
Get full text
Journal Article -
20
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis
Published in Blood (03-12-2015)“…Peroxiredoxin-2 (Prx2), a typical 2-cysteine (Cys) peroxiredoxin, is a key anti-oxidant system in both normal and pathological erythropoiesis characterized by…”
Get full text
Journal Article